CJC-1295
CJC-1295 DAC · DAC:GRF · Drug Affinity Complex Growth Releasing Factor
A long-acting GHRH analogue with a Drug Affinity Complex that extends its half-life dramatically, allowing weekly dosing for sustained GH elevation.
Half-Life
~8 days (DAC version), ~30 min (no-DAC version)
MW
3647.3 Da
Amino Acids
30 AA
Evidence
Moderate Evidence
Regulatory Status
Research compound. Not approved for clinical use.
Research reference values only. Confirm all parameters with current literature and your clinician.
Looking for multi-compound protocols?
Browse educational protocol discussions that include CJC-1295.
Related Compounds
Ipamorelin
A highly selective GH secretagogue and ghrelin receptor agonist known for clean GH release without significant cortisol or prolactin stimulation.
Sermorelin
A 29-amino acid truncated analogue of endogenous GHRH, FDA-approved for pediatric GHD and widely researched for anti-aging and body composition.
GHRP-2
A potent GH secretagogue with strong ghrelin receptor activity, producing significant GH pulses with some cortisol and prolactin elevation.
GHRP-6
One of the original GH secretagogue peptides, notable for strong hunger stimulation alongside robust GH release.
Educational Disclaimer: All information on this page is for educational and research purposes only. This does not constitute medical advice, diagnosis, or treatment recommendation. Consult a qualified healthcare professional.